XML 46 R29.htm IDEA: XBRL DOCUMENT
v3.21.2

Warrants | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2021 | Dec. 31, 2020
Warrants and Rights Note Disclosure [Abstract] |  |
Warrants | 14. Warrants During the three months ended March 31, 2021 a total of 15,450,693 warrants were exercised for 15,450,693 common shares. 14,660,450 warrants were exercised at $0.20 per share, the remaining 790,243 warrants were exercised on a cashless basis, refer to note 5. As of March 31, 2021 15,390,043 common shares were issued with the remaining 60,650 common shares issued subsequent to the period ended. During the three months ended March 31, 2021 the Company issued 30,048,199 and 30,499,800 warrants convertible to 1 and 2 common shares each exercisable for a period of 12 and 18 months respectively. The warrants were issued in connection with the Reg-A public offering and private placement offering respectively. The exercise price of the warrants is $0.20 per share. During the three month ended March 31, 2021 the Company and warrant holder reached an agreement to amend a previous warrant agreement. The Company will issue an additional 150,000 warrants for a total of 250,000 warrants. The exercisable period of the warrants was also amended to a period of five years beginning on January 14, 2021. The warrants are convertible to 1 common share each exercisable at $2 per share. As of March 31, 2021 the Company has the following warrants outstanding:
Exercise price |  |  | Number outstanding |  |  | Remaining Contractual Life (Years) |  |  | Expiry date
$ | 0.20 |  |  |  | 225,000 |  |  |  | 0.67 |  |  | December 1, 2021
$ | 0.20 |  |  |  | 25,349,050 |  |  |  | 0.80 |  |  | February 24, 2022
$ | 2.00 |  |  |  | 250,000 |  |  |  | 1.33 |  |  | April 29, 2022
$ | 0.10 |  |  |  | 109,757 |  |  |  | 3.91 |  |  | February 25, 2025
$ | 0.12 |  |  |  | 1,250,000 |  |  |  | 3.97 |  |  | March 20, 2025
$ | 0.20 |  |  |  | 30,499,800 |  |  |  | 1.50 |  |  | October 1, 2022
|  |  |  |  | 57,683,607 |  |  |  | 2.03 |  |  |
|  | March 31, 2021 |  |  | December 31, 2020 |
|  | Number of warrants |  |  | Weighted average price |  |  | Number of warrants |  |  | Weighted average price |
Balance, beginning of year |  |  | 12,436,301 |  |  | $ | 0.20 |  |  |  | - |  |  | $ | - |
Issuance |  |  | 60,697,999 |  |  | $ | 0.21 |  |  |  | 12,436,301 |  |  | $ | 0.20 |
Exercise |  |  | (15,450,693 | ) |  | $ | (0.19 | ) |  |  | - |  |  | $ | - |
Balance, end of period |  |  | 57,683,607 |  |  | $ | 0.22 |  |  |  | 12,436,301 |  |  | $ | 0.20 |
| 22. Warrants During the year ended December 31, 2020 the Company issued 900,000 warrants convertible to one common share each with an exercise period of 5 years. The exercise price of the warrants is $0.10 per share (subject to adjustment) and may be exercised on a cashless basis, refer to note 8. Refer to notes 25 for subsequent exercise of 790,243 warrants. The fair value of the warrants was calculated using the Black-Scholes pricing model and using the following assumptions:
Discount rate |  |  | 1.16 | %
Expected volatility |  |  | 255 | %
Expected life (years) |  |  | 5 |
Exercise price |  | $ | 0.10 |
Stock price |  | $ | 0.27 |
During the year ended December 31, 2020, the Company issued 1,250,000 and 100,000 warrants convertible to one common share each exercisable until March 30, 2025 and April 29, 2022 respectively. The warrants were issued in connection with a subscriptions payable and advisory agreement. The exercise price of the warrants are $0.12 and $2.00 per share. Refer to note 25 for subsequent issuance of an additional 150,000 warrant. The fair value of the 1,250,000 warrants was calculated using the Black-Scholes pricing model and using the following assumptions:
Discount rate |  |  | 0.025 | %
Expected volatility |  |  | 249 | %
Expected life (years) |  |  | 5 |
Exercise price |  | $ | 0.12 |
Stock price |  | $ | 0.06 |
The fair value of the 100,000 warrants was calculated using the Black-Scholes pricing model and using the following assumptions:
Discount rate |  |  | 2.27 | %
Expected volatility |  |  | 297 | %
Expected life (years) |  |  | 3 |
Exercise price |  | $ | 2 |
Stock price |  | $ | 0.13 |
During the year ended December 31, 2020 the Company issued 225,000 warrants in connection to a advertising agreement and 9,961,301 warrants related to the Reg-A public offering. The warrants are convertible at a rate of 1:1 common share, exercisable until December 1 and 22, 2021 respectively. The exercise price of the warrants are $0.20 per share. The fair value of the 225,000 warrants was calculated using the Black-Scholes pricing model and using the following assumptions:
Discount rate |  |  | 0.12 | %
Expected volatility |  |  | 244 | %
Expected life (years) |  |  | 1 |
Exercise price |  | $ | 0.20 |
Stock price |  | $ | 0.17 |
The fair value of the 9,961,301 warrants was calculated using the Black-Scholes pricing model and using the following assumptions:
Discount rate |  |  | 0.09 | %
Expected volatility |  |  | 239 | %
Expected life (years) |  |  | 1 |
Exercise price |  | $ | 0.20 |
Stock price |  | $ | 0.13 |
Exercise price |  |  | Number outstanding |  |  | Remaining Contractual Life (Years) |  |  | Expiry date
$ | 0.20 |  |  |  | 225,000 |  |  |  | 0.92 |  |  | December 1, 2021
$ | 0.20 |  |  |  | 9,961,301 |  |  |  | 0.98 |  |  | December 22, 2021
$ | 2.00 |  |  |  | 100,000 |  |  |  | 1.33 |  |  | April 29, 2022
$ | 0.10 |  |  |  | 900,000 |  |  |  | 4.16 |  |  | February 25, 2025
$ | 0.12 |  |  |  | 1,250,000 |  |  |  | 4.22 |  |  | March 20, 2025
|  |  |  |  | 12,436,301 |  |  |  | 2.32 |  |  |
|  | December 31, 2020 |  |  | December 31, 2019 |
|  | Number of warrants |  |  | Weighted average price |  |  | Number of warrants |  |  | Weighted average price |
Balance, beginning of year |  | - |  |  | $ | - |  |  | - |  |  | $ | - |
Issuance |  |  | 12,436,301 |  |  | $ | 0.52 |  |  |  | - |  |  | $ | - |
Balance, end of period |  |  | 12,436,301 |  |  | $ | 0.52 |  |  |  | - |  |  | $ | - |

X
- Definition Warrants [Text Block] + References No definition available. + Details
Name: | WKSP_WarrantsTextBlock
Namespace Prefix: | WKSP_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_WarrantsAndRightsNoteDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration